2Jung K,Elgeti U,Lein M,et al.Ratio of free or comlexed prostate-specific antigen to total PSA:which ratio improves differentiation between benign prosatic hyperplasia and prostate cancer[J]?Clinal Chem,2000,46(1):55～62.
3Lein M,Jung K,Elgeti U,et al.Comparison of the clinical validity of free prostate-spcific antigen,alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis[J].Eur Urol,2001,39(1):57～64.
4Jung K,Stephan C,Elgeti U,et al.Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen＜4 microg/L:are they useful tools for early detection and screening of prostate cancer[J]?Int J Cancer,2001,93(5):759～765.
5Dijkman GA,Debruyne FM.Epidemiology of prostate cancer[J].Eur Urol,1996,30 (3):281-295
6Christensson A,Laurell CB,Lilja H,et al.Enzymatic activity of prostate-specific antigen and its reaction with extracellular serine proteinase inhibitors[J].Eur J Biochem,1996,194(1):755-757
7Stenman U,Leinonen J,Alfthan H,et al.A complexbetween PSA and a 1-antichymotrypsin is the major form of PSA in serum of patients with prostatic cancer:assay of the complex improves clinical sensitivity for cancer[J].Cancer Res,1991,51(1):222-227
8Lilja H,Christensson A,Dahlen U,et al.Prostate-specific antigen in human serum occur predominantly in complex with alpha-1-antichymotrypsin[J].Clin Chem,1991,37 (4):1618 -1625
9Lilja H,Haese A,Bjork T,et al.Significance and metabolism of complexed and noncomplexed prostate-specific antigen (PSA)forms and human glandular kallikrein 2 (hk2) in localized prostate cancer before and after radical prostatectomy[J].J Urol,1999,162(2):2029 -2034
10Leinonen J,Stenman UH.Complex formation between PSA isoenzymes and prostate inhibitors[J].J Urol,1996,155 (1):1099 -1103
